- Ophthalmic surgery
- Osteoarthritis
- Dermal fillers
- Vesicoureteral Reflux (VUR)
hyaluronic acid market size was valued at USD 8.04 billion in 2022 and is expected to reach USD 13.02 billion by 2029, at a CAGR of 8.6% during the forecast period 2023-2029. Hyaluronic acid is a substance that is naturally present in the human body. A higher concentration of hyaluronic acid is present in the fluids in the eyes and joints. Hyaluronic acid is used in various treatments such as joint disorders, including osteoarthritis. The FDA has approved the use of hyaluronic acid during certain eye surgeries such as cataract removal, corneal transplantation, and repair of a detached retina and other eye injuries. Hyaluronic acid is also used in cosmetic treatments.
Hyaluronic Acid Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
8.6%
Largest Market
North-America
Fastest Growing Market
Asia Pacific
Hyaluronic Acid Market Dynamics
The increasing geriatric population considerable increases in prevalence of diseases such ulcers, eye diseases and osteoarthritis is likely to drive the growth of the hyaluronic acid market. The growing use of the hyaluronic acid for the treatments such as dry eyes, mouth sores and increasing popularity of the non-surgical procedures with cost-effectiveness expected to drive the growth of the hyaluronic acid market. The non-surgical procedures in aesthetics include botulinum toxin, dermal fillers, laser treatments, chemical peels, and microdermabrasion. The hyaluronic acid injection heals damage caused by scars, wounds, lines. The rising demand for the hyaluronic acid for cosmetic treatments and usage of the hyaluronic acid surfaces in various cardiovascular implants, such as stents and vascular grafts is also driving the growth of the hyaluronic acid market. However, the higher cost of the hyaluronic acid products is likely to hamper the growth of the market.
North-America Got Significant Share
Hyaluronic Acid Market Regional Analysis
Geographically, global hyaluronic acid market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America is the dominant market in global hyaluronic acid market. Owing to the rising geriatric population and growing awareness about the cost-effective non-surgical procedures is driving the aesthetics market in the region. The Asia Pacific is expected to be the fastest growing region during the forecast period. The increasing geriatric population in the countries of China and Japan provides a large patient pool for the hyaluronic acid treatment in various segments such as osteoarthritis and age related skin issues. Increasing awareness about applications of hyaluronic acid products and its efficacy is also adding fuel to the hyaluronic acid market in this region.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Hyaluronic Acid Market Segmentation
By Application
By Route Administration
- Oral
- Parenteral
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Product
- Single-injection,
- Three-injection
- Five-injection
Frequently Asked Questions
North America holds highest share in 2022.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
| 1.Executive Summary |
| 2.Global Hyaluronic Acid Market Introduction |
| 2.1.Global Hyaluronic Acid Market - Taxonomy |
| 2.2.Global Hyaluronic Acid Market - Definitions |
| 2.2.1.Product |
| 2.2.2.Route of administration |
| 2.2.3.Application |
| 2.2.4.Distribution Channel |
| 2.2.5.Region |
| 3.Global Hyaluronic Acid Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Hyaluronic Acid Market Analysis, 2018-2022 and Forecast 2023-2029 |
| 4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Hyaluronic Acid Market By Product, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 5.1. Single-injection, |
| 5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Three-injection |
| 5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Five-injection |
| 5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6.Global Hyaluronic Acid Market By Route of administration, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 6.1. Oral |
| 6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Parenteral |
| 6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 7.Global Hyaluronic Acid Market By Application, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 7.1. Ophthalmic surgery |
| 7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Osteoarthritis |
| 7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Dermal fillers |
| 7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8.Global Hyaluronic Acid Market By Distribution Channel, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 8.1. Hospital Pharmacies |
| 8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Retail Pharmacies |
| 8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Online Pharmacies |
| 8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 9.Global Hyaluronic Acid Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10.North America Hyaluronic Acid Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 10.1. Product Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Single-injection, |
| 10.1.2.Three-injection |
| 10.1.3.Five-injection |
| 10.2. Route of administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Oral |
| 10.2.2.Parenteral |
| 10.3. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Ophthalmic surgery |
| 10.3.2.Osteoarthritis |
| 10.3.3.Dermal fillers |
| 10.4. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Hospital Pharmacies |
| 10.4.2.Retail Pharmacies |
| 10.4.3.Online Pharmacies |
| 10.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11.Europe Hyaluronic Acid Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 11.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Single-injection, |
| 11.1.2.Three-injection |
| 11.1.3.Five-injection |
| 11.2. Route of administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Oral |
| 11.2.2.Parenteral |
| 11.3. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Ophthalmic surgery |
| 11.3.2.Osteoarthritis |
| 11.3.3.Dermal fillers |
| 11.4. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Hospital Pharmacies |
| 11.4.2.Retail Pharmacies |
| 11.4.3.Online Pharmacies |
| 11.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 11.5.6.Rest of EU |
| 12.Asia Pacific (APAC) Hyaluronic Acid Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 12.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Single-injection, |
| 12.1.2.Three-injection |
| 12.1.3.Five-injection |
| 12.2. Route of administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Oral |
| 12.2.2.Parenteral |
| 12.3. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Ophthalmic surgery |
| 12.3.2.Osteoarthritis |
| 12.3.3.Dermal fillers |
| 12.4. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Hospital Pharmacies |
| 12.4.2.Retail Pharmacies |
| 12.4.3.Online Pharmacies |
| 12.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13.Middle East and Africa (MEA) Hyaluronic Acid Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 13.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Single-injection, |
| 13.1.2.Three-injection |
| 13.1.3.Five-injection |
| 13.2. Route of administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Oral |
| 13.2.2.Parenteral |
| 13.3. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Ophthalmic surgery |
| 13.3.2.Osteoarthritis |
| 13.3.3.Dermal fillers |
| 13.4. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Hospital Pharmacies |
| 13.4.2.Retail Pharmacies |
| 13.4.3.Online Pharmacies |
| 13.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14.Latin America Hyaluronic Acid Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 14.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Single-injection, |
| 14.1.2.Three-injection |
| 14.1.3.Five-injection |
| 14.2. Route of administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Oral |
| 14.2.2.Parenteral |
| 14.3. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Ophthalmic surgery |
| 14.3.2.Osteoarthritis |
| 14.3.3.Dermal fillers |
| 14.4. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Hospital Pharmacies |
| 14.4.2.Retail Pharmacies |
| 14.4.3.Online Pharmacies |
| 14.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Alcon, Inc (U.S) |
| 15.2.2.Allergan, Inc. (Ireland) |
| 15.2.3.Ferring Pharmaceuticals, Inc. (Switzerland) |
| 15.2.4.Fidia Farmaceutici SpA (Italy) |
| 15.2.5.GALDERMA S.A. (Switzerland) |
| 15.2.6.Hyaltech Ltd (UK) |
| 15.2.7.Anika Therapeutics, Inc (U.S) |
| 15.2.8.LifeCore Biomedical LLC (U.S) |
| 15.2.9.Salix Pharmaceuticals, Inc. (U.S) |
| 15.2.10.Smith & Nephew plc (UK) |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
- Alcon, Inc (U.S)
- Allergan, Inc. (Ireland)
- Ferring Pharmaceuticals, Inc. (Switzerland)
- Fidia Farmaceutici SpA (Italy)
- GALDERMA S.A. (Switzerland)
- Hyaltech Ltd (UK)
- Anika Therapeutics, Inc (U.S)
- LifeCore Biomedical LLC (U.S)
- Salix Pharmaceuticals, Inc. (U.S)
- Smith & Nephew plc (UK)